| BCBS Florida Coverage Guidelines | Linvoseltamab-gcpt (Lynozyfic) IV Infusion (09-J5000-27) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Minimally Invasive Fusion Techniques (02-61000-36) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Mirikizumab-mrkz (Omvoh®) Injection and (09-J4000-71) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Nemolizumab-ilto (Nemluvio) Injection (09-J4000-99) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | New-To-Market Program for Medical Benefit (09-J4000-30) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Nitisinone (Orfadin®, Nityr™, Harliku™) (09-J1000-27) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Non-Covered Services (09-A0000-00) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Ozanimod (Zeposia®) Capsules (09-J3000-70) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Tibial Nerve Stimulation (02-64000-01) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Electrical Nerve Stimulation (02-61000-03) | 2026-01-01 |